Seizing over the Conundrums of SAH Seizure Prophylaxis
Mohammad Sistanizad*and Majid Mokhtari
Faculty of Pharmacy, Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Iran
- *Corresponding Author:
- Mohammad sistanizad
Faculty of Pharmacy, Department
of Clinical Pharmacy, Shahid Beheshti
University of Medical Sciences, Iran
E-mail: [email protected]
Received Date: June 30, 2017 Accepted Date: July 18, 2017 Published Date: July 20, 2017
Citation: Sistanizad M, Mokhtari M (2017) Seizing over the Conundrums of SAH Seizure Prophylaxis. J Trauma Treat 6: 383. doi: 10.4172/2167-1222.1000383
Copyright: © 2017 Sistanizad M, et al. This is an open-access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Aneurysmal subarachnoid hemorrhage (SAH), a potentially catastrophic stroke, which occurs at a relatively younger age (median 55 years), afflicts over 30,000 patients a year in the USA. It accounts for 3% to 5% of all strokes and 4.4% of deaths from stroke belong to this group of patients. It carries high rate of morbidity (25%) and case fatality (35%) in most series.